iA Global Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.26M Sell
136,154
-18,677
-12% -$1.09M 0.12% 152
2025
Q4
$8.35M Sell
154,831
-3,849
-2% -$185K 0.11% 147
2025
Q3
$7.16M Buy
158,680
+27,347
+21% +$1.28M 0.1% 155
2025
Q2
$6.08M Buy
131,333
+44,249
+51% +$2.17M 0.09% 158
2025
Q1
$5.31M Sell
87,084
-11,648
-12% -$679K 0.09% 159
2024
Q4
$5.58M Buy
98,732
+21,957
+29% +$1.23M 0.1% 149
2024
Q3
$3.97M Buy
76,775
+34,418
+81% +$1.61M 0.07% 186
2024
Q2
$1.76M Sell
42,357
-72,216
-63% -$3.23M 0.03% 242
2024
Q1
$6.21M Buy
114,573
+2,623
+2% +$134K 0.13% 133
2023
Q4
$5.74M Sell
111,950
-233,938
-68% -$12.3M 0.13% 129
2023
Q3
$20.1M Buy
345,888
+4,191
+1% +$257K 0.53% 46
2023
Q2
$21.9M Buy
+341,697
New +$22.9M 0.58% 38

Other funds holding BMY

iA Global Asset Management's BMY Position: Q1 2026 in Review

iA Global Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, selling an estimated $1.09M and leaving 136,154 shares worth $8.26M. The position accounts for 0.12% of the portfolio, ranked #152.

iA Global Asset Management first reported a position in BMY in Q2 2023 and has held it in 12 quarters since. The position peaked at $21.9M in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • iA Global Asset Management held 136,154 shares of Bristol-Myers Squibb worth $8.26M as of Q1 2026.
  • iA Global Asset Management sold 18,677 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.09M.
  • Bristol-Myers Squibb made up 0.12% of iA Global Asset Management's portfolio in Q1 2026, its #152 holding.
  • iA Global Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and has held it in 12 quarters since.
  • iA Global Asset Management's Bristol-Myers Squibb position peaked at $21.9M in Q2 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.